These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 37918804)

  • 1. Understanding and exploiting the roles of O-GlcNAc in neurodegenerative diseases.
    Pratt MR; Vocadlo DJ
    J Biol Chem; 2023 Dec; 299(12):105411. PubMed ID: 37918804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. O-GlcNAcylation and neurodegeneration.
    Wani WY; Chatham JC; Darley-Usmar V; McMahon LL; Zhang J
    Brain Res Bull; 2017 Jul; 133():80-87. PubMed ID: 27497832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. O-GlcNAc and neurodegeneration: biochemical mechanisms and potential roles in Alzheimer's disease and beyond.
    Yuzwa SA; Vocadlo DJ
    Chem Soc Rev; 2014 Oct; 43(19):6839-58. PubMed ID: 24759912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological inhibition of O-GlcNAcase (OGA) prevents cognitive decline and amyloid plaque formation in bigenic tau/APP mutant mice.
    Yuzwa SA; Shan X; Jones BA; Zhao G; Woodward ML; Li X; Zhu Y; McEachern EJ; Silverman MA; Watson NV; Gong CX; Vocadlo DJ
    Mol Neurodegener; 2014 Oct; 9():42. PubMed ID: 25344697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Interrogation to Crack the Case of O-GlcNAc.
    Estevez A; Zhu D; Blankenship C; Jiang J
    Chemistry; 2020 Sep; 26(53):12086-12100. PubMed ID: 32207184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological Inhibition of O-GlcNAcase Enhances Autophagy in Brain through an mTOR-Independent Pathway.
    Zhu Y; Shan X; Safarpour F; Erro Go N; Li N; Shan A; Huang MC; Deen M; Holicek V; Ashmus R; Madden Z; Gorski S; Silverman MA; Vocadlo DJ
    ACS Chem Neurosci; 2018 Jun; 9(6):1366-1379. PubMed ID: 29460617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nutrient-driven O-GlcNAc in proteostasis and neurodegeneration.
    Akan I; Olivier-Van Stichelen S; Bond MR; Hanover JA
    J Neurochem; 2018 Jan; 144(1):7-34. PubMed ID: 29049853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elucidating the protein substrate recognition of O-GlcNAc transferase (OGT) toward O-GlcNAcase (OGA) using a GlcNAc electrophilic probe.
    Kositzke A; Fan D; Wang A; Li H; Worth M; Jiang J
    Int J Biol Macromol; 2021 Feb; 169():51-59. PubMed ID: 33333092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased O-GlcNAc levels correlate with decreased O-GlcNAcase levels in Alzheimer disease brain.
    Förster S; Welleford AS; Triplett JC; Sultana R; Schmitz B; Butterfield DA
    Biochim Biophys Acta; 2014 Sep; 1842(9):1333-9. PubMed ID: 24859566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical tools to explore nutrient-driven O-GlcNAc cycling.
    Kim EJ; Bond MR; Love DC; Hanover JA
    Crit Rev Biochem Mol Biol; 2014; 49(4):327-42. PubMed ID: 25039763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of O-GlcNAc alteration on Alzheimer-like neurodegeneration in SK-N-SH cells.
    Ding N; Peng P; Chu YJ; Wang JJ; Chen SY; Arulthas R; Deng YQ
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2018 Sep; 162(3):243-248. PubMed ID: 30181664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in O-Linked N-Acetylglucosamine (O-GlcNAc) Homeostasis Activate the p53 Pathway in Ovarian Cancer Cells.
    de Queiroz RM; Madan R; Chien J; Dias WB; Slawson C
    J Biol Chem; 2016 Sep; 291(36):18897-914. PubMed ID: 27402830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing O-GlcNAc slows neurodegeneration and stabilizes tau against aggregation.
    Yuzwa SA; Shan X; Macauley MS; Clark T; Skorobogatko Y; Vosseller K; Vocadlo DJ
    Nat Chem Biol; 2012 Feb; 8(4):393-9. PubMed ID: 22366723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The O-GlcNAc Modification of Recombinant Tau Protein and Characterization of the O-GlcNAc Pattern for Functional Study.
    El Hajjar L; Bridot C; Nguyen M; Cantrelle FX; Landrieu I; Smet-Nocca C
    Methods Mol Biol; 2024; 2754():237-269. PubMed ID: 38512671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic recoding to dissect the roles of site-specific protein O-GlcNAcylation.
    Gorelik A; Bartual SG; Borodkin VS; Varghese J; Ferenbach AT; van Aalten DMF
    Nat Struct Mol Biol; 2019 Nov; 26(11):1071-1077. PubMed ID: 31695185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional O-GlcNAc modifications: implications in molecular regulation and pathophysiology.
    Vaidyanathan K; Durning S; Wells L
    Crit Rev Biochem Mol Biol; 2014; 49(2):140-163. PubMed ID: 24524620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. O-GlcNAcylation increases non-amyloidogenic processing of the amyloid-β precursor protein (APP).
    Jacobsen KT; Iverfeldt K
    Biochem Biophys Res Commun; 2011 Jan; 404(3):882-6. PubMed ID: 21182826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. O-GlcNAc processing enzymes: catalytic mechanisms, substrate specificity, and enzyme regulation.
    Vocadlo DJ
    Curr Opin Chem Biol; 2012 Dec; 16(5-6):488-97. PubMed ID: 23146438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic O-GlcNAcylation and its roles in the cellular stress response and homeostasis.
    Groves JA; Lee A; Yildirir G; Zachara NE
    Cell Stress Chaperones; 2013 Sep; 18(5):535-58. PubMed ID: 23620203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of a compensatory regulation of colonic O-GlcNAc transferase and O-GlcNAcase expression in response to disruption of O-GlcNAc homeostasis.
    Decourcelle A; Loison I; Baldini S; Leprince D; Dehennaut V
    Biochem Biophys Res Commun; 2020 Jan; 521(1):125-130. PubMed ID: 31630803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.